Aveo Kicks Investor Suit Over Losses From Kidney Drugs
A Massachusetts federal judge on Friday dismissed a proposed shareholder class action accusing Aveo Pharmaceuticals Inc. of deceiving investors about the riskiness of its kidney cancer drug, finding the investors have...To view the full article, register now.
Already a subscriber? Click here to view full article